El ácido fólico en la prevención de los defectos congénitos
Keywords:
ácido fólicoDownloads
References
Lardoeyt Ferrer R, Taboada Lugo N, Torres Sánchez Y, Viñas Portilla C. Fundamentos del ácido fólico en la prevención primaria farmacológica de defectos congénitos. Rev Cubana Med Gen Integr [Internet]. 2005 [citado 2014 Feb 05];21(1-2). Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-21252005000100016&script=sci_arttext
Dhaulakhandi DB, Rohilla S, Rattan KN. Neural Tube Defects: Review of Experimental Evidence on Stem Cell Therapy and Newer Treatment Options. Fetal Diagn Ther [Internet]. 2010 [citado 2014 Feb 05];28(2):72-8. Disponible en: http://www.karger.com/Article/Pdf/318201
Blom HJ, Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J Inherit Metab Dis [Internet]. 2011 [citado 2014 Feb 04];34(1):75-81. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026708/pdf/10545_2010_Article_9177.pdf
Wehby GL, Murray JC. Folic acid and orofacial clefts: a review of the evidence. Oral Dis [Internet]. 2010 [citado 2014 Feb 04];16(1):11-9. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922396/pdf/nihms216894.pdf
Brito A, Hertrampf E, Olivares M, Gaitán D, Sánchez H, Allen L, et al. Folatos y vitamina B12 en la salud humana. Rev. méd. Chile [Internet]. 2012 [citado 2014 Feb 04] ; 140(11): 1464-1475. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012001100014&lng=en
MINSAP. Objetivos de trabajo y criterios de medidas 2014. [Internet]. La Habana: MINSAP; 2013 [citado 2014 Feb 04]. Disponible en: http://www.bvs.sld.cu/libros/objetivos2014/objetivos_2014.pdf
Published
How to Cite
Issue
Section
License
Medimay protects copyright from the very first moment the submission is made, but upon publication it assumes a Creative Commons 4.0 (cc-by-nc) license, which allows the use of the work to share (copy and redistribute the material in any medium or format) and adapt (remix, transform and build from the material) as long as exclusive mention is made of the publication in the journal as a primary source, prohibiting its commercialization. The author always retains his/her right.